cbdMD (YCBD) Free Cash Flow (2016 - 2025)
cbdMD's (YCBD) quarterly Free Cash Flow came in at -$977266.0 in Q4 2025, down 102.61% year-on-year from $37.4 million in Q4 2024, and down 301.25% quarter-over-quarter from -$243553.0 in Q3 2025.
cbdMD (YCBD) Free Cash Flow (2016 - 2025) Analysis & Trends
cbdMD has disclosed Free Cash Flow across 10 years of filings, most recently posting -$977266.0 for Q4 2025.
- Free Cash Flow for Q4 2025 came in at -$977266.0, down 102.61% year-over-year; the trailing twelve-month figure through Dec 2025 was -$2.1 million (down 190.14% YoY), and the FY2025 annual result was -$1.6 million, down 201.5% from the prior year.
- Free Cash Flow came in at -$977266.0 for Q4 2025 at cbdMD, down from -$243553.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $289779.0 in Q2 2024 to a low of -$5.7 million in Q4 2021.
- The 5-year median for Free Cash Flow is -$841470.5 (2025), against an average of -$1.8 million.
- Across the five-year window, Free Cash Flow tumbled 3122.64% in 2021 and jumped 184.49% in 2024, its largest moves.
- cbdMD's Free Cash Flow stood at -$5.7 million in 2021, then soared by 60.67% to -$2.2 million in 2022, then surged by 87.04% to -$290515.0 in 2023, then sank by 66.03% to -$482336.0 in 2024, then tumbled by 102.61% to -$977266.0 in 2025.
- The last three Free Cash Flow figures came in at -$977266.0 (Q4 2025), -$243553.0 (Q3 2025), and -$705675.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | cbdMD | 3,884.57 | -3.38 Mn | 3.00 Mn | -977,266.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -977,266.00 |
| Dec 31, 2025 | -977,266.00 |
| Sep 30, 2025 | -243,553.00 |
| Sep 30, 2025 | -243,553.00 |
| Jun 30, 2025 | -705,675.00 |
| Jun 30, 2025 | -705,675.00 |
| Mar 31, 2025 | -204,983.00 |
| Mar 31, 2025 | -204,983.00 |
| Dec 31, 2024 | -482,336.00 |
| Dec 31, 2024 | -482,336.00 |
| Sep 30, 2024 | 157,377.00 |
| Sep 30, 2024 | 157,377.00 |
| Jun 30, 2024 | 289,779.00 |
| Jun 30, 2024 | 289,779.00 |
| Mar 31, 2024 | -699,448.00 |
| Mar 31, 2024 | -699,448.00 |
| Dec 31, 2023 | -290,515.00 |
| Dec 31, 2023 | -290,515.00 |
| Sep 30, 2023 | -383,681.00 |
| Sep 30, 2023 | -383,681.00 |